PAVBLU
NDC 55513-065, aflibercept-ayyh, injection, solution, from Amgen, Inc.
- Product NDC
- 55513-065
- Status
- Listed
- Labeler
- Amgen, Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761298
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55513-065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AFLIBERCEPT2 mg/.05mL
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55513-065-01 | 55513006501 | 1 VIAL in 1 CARTON (55513-065-01) / .05 mL in 1 VIAL |
| 55513-065-96 | 55513006596 | 1 VIAL in 1 CARTON (55513-065-96) / .05 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c61062f3-80ec-4a20-8c28-46e468592a06Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=55513-065
Use it
Look up 55513-065 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55513-065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55513-065. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.